hematopoietic system
N |
• platelet number and bleed time, and intestinal and vascular smooth muscle are normal
|
• activated platelets bind more fibrinogen than wild-type platelets and pretreatment with 100 uM 8-pCPT-cGMP or 110 uM Sp-5,6-DCL-cBIMPS does not reduce fibrinogen binding as it does in wild-type mice
|
• collagen-induced aggregatory response is accelerated such that platelets reach 50% of maximum aggregatory response to 5 ug/ml collagen in 89+/-4 s compared to 106+/-4 s for wild-type mice
• inhibition of aggregation induced by 10, 20 or 100 uM 8-pCPT-cGMP is reduced (percent inhibition at 50 uM, 21.6% compared to 77.8% in wild-type platelets)
• inhibition of aggregation induced by 6 and 10 uM Sp-5,6-DCL-cBIMPS is reduced (percent inhibition at 6 uM, 30.6% compared to 73.6% in wild-type platelets)
|
homeostasis/metabolism
• activated platelets bind more fibrinogen than wild-type platelets and pretreatment with 100 uM 8-pCPT-cGMP or 110 uM Sp-5,6-DCL-cBIMPS does not reduce fibrinogen binding as it does in wild-type mice
|
• collagen-induced aggregatory response is accelerated such that platelets reach 50% of maximum aggregatory response to 5 ug/ml collagen in 89+/-4 s compared to 106+/-4 s for wild-type mice
• inhibition of aggregation induced by 10, 20 or 100 uM 8-pCPT-cGMP is reduced (percent inhibition at 50 uM, 21.6% compared to 77.8% in wild-type platelets)
• inhibition of aggregation induced by 6 and 10 uM Sp-5,6-DCL-cBIMPS is reduced (percent inhibition at 6 uM, 30.6% compared to 73.6% in wild-type platelets)
|